Founded in 1993, Tianma Tianji is an innovative leader in the biopharma and biotechnology industries, specializing in the production of biochemicals such as peptide drugs and amino acid derivatives. The company's extensive product portfolio includes small-volume injections, freeze-dried powder injections, peptides, and small-molecule chemical raw materials, among others. Their slogan "Crafting Exquisite Biochemical Solutions" reflects their commitment to providing high-quality pharmaceutical products. In December 2010, Tianma Tianji secured a significant Private Equity Round investment from Mandarin Capital Partners, a testament to their potential for growth and innovation in the industry.
No recent news or press coverage available for Tianma Tianji.